BioCardia, Inc.
BCDA
$2.10
-$0.17-7.49%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | -- | -93.02% | -14.06% | -87.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00% | -- | -93.02% | -14.06% | -87.74% |
| Cost of Revenue | -234.69% | -50.27% | -65.43% | -47.94% | -47.45% |
| Gross Profit | 236.22% | 38.55% | 64.91% | 48.88% | 45.42% |
| SG&A Expenses | -3.72% | -23.82% | -27.86% | -8.49% | 1.84% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.68% | -40.58% | -52.73% | -34.81% | -32.87% |
| Operating Income | -11.37% | 32.41% | 52.23% | 35.19% | 30.95% |
| Income Before Tax | -10.81% | 32.52% | 51.93% | 35.25% | 31.57% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.81% | 32.52% | 51.93% | 35.25% | 31.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.81% | 32.52% | 51.93% | 35.25% | 31.57% |
| EBIT | -11.37% | 32.41% | 52.23% | 35.19% | 30.95% |
| EBITDA | -11.72% | 32.48% | 52.43% | 35.32% | 31.13% |
| EPS Basic | 63.72% | 65.61% | 65.20% | 48.02% | 44.37% |
| Normalized Basic EPS | 63.72% | 65.60% | 65.19% | 48.02% | 44.37% |
| EPS Diluted | 27.27% | 65.61% | 65.20% | 48.02% | 44.37% |
| Normalized Diluted EPS | 63.72% | 65.60% | 65.19% | 48.02% | 44.37% |
| Average Basic Shares Outstanding | 205.47% | 96.22% | 38.12% | 24.56% | 23.02% |
| Average Diluted Shares Outstanding | 205.47% | 96.22% | 38.12% | 24.56% | 23.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
